TELA Bio (TELA) Gains from Sales and Divestitures (2021 - 2026)
TELA Bio's quarterly Gains from Sales and Divestitures came in at $305278.0 in Q1 2026, up 53.96% year-on-year from $198280.0 in Q1 2025, and up 9.12% quarter-over-quarter from $279765.0 in Q4 2025.
TELA Bio has reported Gains from Sales and Divestitures for 6 years, with the latest figure at $305278.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 53.96% year-over-year to $305278.0; the trailing twelve-month figure through Mar 2026 stood at $305278.0 (up 53.96% YoY), and the FY2025 full-year result was $279765.0, up 46.34% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $305278.0, up from $279765.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $305278.0 in Q1 2026, with the low at $38908.0 in Q1 2022.
- Average Gains from Sales and Divestitures over 5 years is $146776.1, with a median of $141014.0 recorded in 2024.
- Year-over-year, Gains from Sales and Divestitures surged 239.86% in 2022 and soared 40.61% in 2025.
- Tracing TELA's Gains from Sales and Divestitures over 5 years: stood at $40783.0 in 2022, then jumped by 149.02% to $101559.0 in 2023, then jumped by 88.24% to $191175.0 in 2024, then soared by 46.34% to $279765.0 in 2025, then gained by 9.12% to $305278.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $305278.0 (Q1 2026), $279765.0 (Q4 2025), and $268601.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,278.00 |
| Mar 31, 2026 | 305,278.00 |
| Dec 31, 2025 | 279,765.00 |
| Dec 31, 2025 | 279,765.00 |
| Sep 30, 2025 | 268,601.00 |
| Sep 30, 2025 | 268,601.00 |
| Jun 30, 2025 | 231,011.00 |
| Jun 30, 2025 | 231,011.00 |
| Mar 31, 2025 | 198,280.00 |
| Mar 31, 2025 | 198,280.00 |
| Dec 31, 2024 | 191,175.00 |
| Dec 31, 2024 | 191,175.00 |
| Sep 30, 2024 | 178,836.00 |
| Sep 30, 2024 | 178,836.00 |
| Jun 30, 2024 | 164,134.00 |
| Jun 30, 2024 | 164,134.00 |
| Mar 31, 2024 | 141,014.00 |
| Mar 31, 2024 | 141,014.00 |
| Dec 31, 2023 | 101,559.00 |
| Dec 31, 2023 | 101,559.00 |
| Sep 30, 2023 | 99,684.00 |
| Sep 30, 2023 | 99,684.00 |
| Jun 30, 2023 | 97,809.00 |
| Jun 30, 2023 | 97,809.00 |
| Mar 31, 2023 | 78,666.00 |
| Mar 31, 2023 | 78,666.00 |
| Dec 31, 2022 | 40,783.00 |
| Dec 31, 2022 | 40,783.00 |
| Sep 30, 2022 | 40,783.00 |
| Sep 30, 2022 | 40,783.00 |
| Jun 30, 2022 | 38,908.00 |
| Jun 30, 2022 | 38,908.00 |
| Mar 31, 2022 | 38,908.00 |
| Mar 31, 2022 | 38,908.00 |
| Dec 31, 2021 | 12,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |